The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis, structure-activity relationship and antiviral activity of indole-containing inhibitors of Flavivirus NS2B-NS3 protease.EBI
Baylor College Of Medicine
SAR of novel benzothiazoles targeting an allosteric pocket of DENV and ZIKV NS2B/NS3 proteases.EBI
Johannes Gutenberg-University
Synthesis, Structure-Activity Relationships, and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease.EBI
Baylor College Of Medicine
Inhibitors of the Zika virus protease NS2B-NS3.EBI
Australian National University
Catching a Moving Target: Comparative Modeling of Flaviviral NS2B-NS3 Reveals Small Molecule Zika Protease Inhibitors.EBI
Freie Universit£T Berlin
Cell-active carbazole derivatives as inhibitors of the zika virus protease.EBI
University Of Patras
Drugs for the Treatment of Zika Virus Infection.EBI
University Of North Carolina At Chapel Hill
Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses.EBI
Federal University Of Alagoas
Proline-Based Allosteric Inhibitors of Zika and Dengue Virus NS2B/NS3 Proteases.EBI
Johannes Gutenberg University Mainz
Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of the Zika Virus NS2B-NS3 Protease.EBI
Australian National University